Huachen Investment announced that Zhejiang Pharmaceutical Group plans to transfer 122 million shares of Inter Group held by Huachen Investment through a free transfer of state-owned shares; at the same time, Zhejiang Guomao entrusts all voting rights corresponding to the 151 million shares of Inter Group it holds to Zhejiang Pharmaceutical Group. After the acquisition is completed, Zhejiang Pharmaceutical Group will directly hold 23.42% of Intel Group's shares and will hold 28.89% of the shares through voting rights entrustment, controlling 61.67% of voting rights in total, and becoming the controlling shareholder of Intel Group.

Huachen Investment announced that Zhejiang Pharmaceutical Group plans to transfer 122 million shares of Inter Group held by Huachen Investment through a free transfer of state-owned shares; at the same time, Zhejiang Guomao entrusts all voting rights corresponding to the 151 million shares of Inter Group it holds to Zhejiang Pharmaceutical Group. After the acquisition is completed, Zhejiang Pharmaceutical Group will directly hold 23.42% of Intel Group's shares and will hold 28.89% of the shares through voting rights entrustment, controlling 61.67% of voting rights in total, and becoming the controlling shareholder of Intel Group.